FIGURE 2
FROM:
Hospitalized avascular necrosis after renal transplantation in the United States
Kevin C Abbott, Robert J Oglesby and Lawrence Y Agodoa
BACK TO ARTICLEFigure 2.
Time to hospitalization for AVN, U.S. renal transplant recipients from July 1, 1994 to 1998. N = 42,096 patients, with a follow-up period truncated at three years post-transplant. The proportion of patients who experienced AVN in the first post-transplant year was 0.26%, compared with 0.83% in the second post-transplant year and 0.84% in the third post-transplant year. As shown, in contrast to prior studies, the risk of AVN was actually lowest in the first transplant year and increased at a similar rate the remaining two years. This may reflect the preferred timing of total hip replacement, which is the definitive therapy for AVN.
